Company profilePharmaceutical#872 of 1,318 in Pakistan✓ No DRAP alerts

MASCON PHARMACAL

Pharmaceutical company · 7 brands · 9 molecules

Ranked #26 of 27 companies in Antiglaucoma Preparations And Miotics

7 registered products 10 pharmaceutical brands 9 distinct molecules 0 DRAP alerts

Company overview

7
registered products
10
pharmaceutical brands
9
distinct molecules
1
therapeutic classes
0
DRAP alerts

MASCON PHARMACAL is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 7 product registrations across 9 distinct molecules. Its portfolio is concentrated in Antiglaucoma Preparations And Miotics. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Tobramycin2 brands
Neomycin1 brand
Eye1 brand
Timolol1 brand
Cefepime1 brand
Dobutamine1 brand

Therapeutic classes

Antiglaucoma Preparations And Miotics · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for MASCON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.